Advanced Skeletal Imaging Redefines the Management of Plasma Cell Disorders
Cet article présente les recommandations d'un groupe d'experts internationaux sur l'utilisation de l'IRM pour évaluer les lésions osseuses chez les patients atteints d'un myélome multiple
In this issue of Journal of Clinical Oncology, Dimopoulos and thought leaders in the field of myeloma, representing the International Myeloma Working Group, provide evidence-based, consensus recommendations on the use of magnetic resonance imaging (MRI) in a number of plasma cell disorders. Their recommendations are practice changing.1 When new techniques are introduced for patient evaluation, they often add expense for patients but do not affect management. These recommendations affect therapeutic decision making for patients with plasma cell disorders and represent an update of earlier International Myeloma Working Group recommendations.2 The paper focuses on the use of MRI. However, data on the use of positron emission tomography (PET) combined with computed tomography (CT) is also applicable to decision making in patients with plasma cell disorders...
Journal of Clinical Oncology , éditorial en libre accès, 2015